Report #2841899

Received May 20, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: Age unknown
State: CO
Recovered: Unknown
Vaccinated: Apr 30, 2025
Onset: Apr 30, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	1	92NN2	—

Symptoms (1)

Product preparation issue

Symptom narrative

a patient was administered only the adjuvant portion or Shingrix; a patient was administered only the adjuvant portion or Shingrix; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a male patient who received Herpes zoster (Shingrix) (batch number 92NN2, expiry date 30-MAR-2027) for prophylaxis. On 30-APR-2025, the patient received the 1st dose of Shingrix. On 30-APR-2025, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: a patient was administered only the adjuvant portion or Shingrix) and inappropriate dose of vaccine administered (Verbatim: a patient was administered only the adjuvant portion or Shingrix). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 08-MAY-2025 The pharmacist reported that a patient was administered only the adjuvant portion or Shingrix (without reconstitution) which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.